{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:41:23Z","timestamp":1778542883462,"version":"3.51.4"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402176, 81402093, 81472296"],"award-info":[{"award-number":["81402176, 81402093, 81472296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20140288"],"award-info":[{"award-number":["BK20140288"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Tamoxifen and fulvestrant, both approved for endocrine therapy, have remarkably increased the prognosis of hormone receptor-positive breast cancer patients. However, acquired resistance to endocrine therapy greatly reduces its clinical efficacy. Accumulating evidence suggests a pivotal role of non-coding RNAs (ncRNAs) in breast cancer endocrine resistance, but the specific functions of ncRNAs in tamoxifen and fulvestrant resistance remain largely unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Microarray analysis was performed for endocrine therapy sensitive (MCF-7), tamoxifen-resistant (LCC2), and dual tamoxifen and fulvestrant-resistant (LCC9) breast cancer cells. Gene ontology and pathway analysis were conducted for functional prediction of the unannotated differentially expressed ncRNAs. Competing endogenous RNA regulatory networks were constructed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We discovered a total of 3,129 long non-coding RNAs (lncRNAs), 13,556 circular RNAs (circRNAs), 132 microRNAs, and 3358 mRNAs that were significantly differentially expressed. We constructed co-expression networks for lncRNA-mRNA, circRNA-mRNA, and microRNA-mRNA. In addition, we established lncRNA-microRNA-mRNA and circRNA-microRNA-mRNA regulatory networks to depict ncRNA crosstalk and transcriptomic regulation of endocrine resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study delineates a comprehensive profiling of ncRNAs in tamoxifen and fulvestrant resistant breast cancer cells, which enriches our understanding of endocrine resistance and sheds new light on identifying novel endocrine resistance biomarkers and potential therapeutic targets to overcome endocrine resistance.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2020.600487","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T20:02:37Z","timestamp":1606248157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Liang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.117","article-title":"ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer","volume":"12","author":"Jeselsohn","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1008","DOI":"10.1038\/cddis.2013.541","article-title":"Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)","volume":"5","author":"Huang","year":"2014","journal-title":"Cell Death Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gde.2017.11.004","article-title":"RNA regulons in cancer and inflammation","volume":"48","author":"Bisogno","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13058-015-0542-y","article-title":"Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA","volume":"17","author":"Hayes","year":"2015","journal-title":"Breast Cancer Res BCR"},{"key":"B8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12943-015-0480-4","article-title":"MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy","volume":"14","author":"Yu","year":"2015","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-019-0747-0","article-title":"The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy","volume":"12","author":"Wang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000495643","article-title":"Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells","volume":"51","author":"Basak","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2017-0055","article-title":"Screening circular RNA related to chemotherapeutic resistance in breast cancer","volume":"9","author":"Gao","year":"2017","journal-title":"Epigenomics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.05.011","article-title":"circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p\/FOXO3a Axis in Breast Cancer","volume":"27","author":"Sang","year":"2019","journal-title":"Mol Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2010.09.001","article-title":"Long noncoding RNAs with enhancer-like function in human cells","volume":"143","author":"Orom","year":"2010","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3975","article-title":"Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity","volume":"18","author":"You","year":"2015","journal-title":"Nat Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell\u2019s functional organization","volume":"5","author":"Barabasi","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm995","article-title":"The microRNA.org resource: targets and expression","volume":"36","author":"Betel","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky962","article-title":"New approach for understanding genome variations in KEGG","volume":"47","author":"Kanehisa","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn653","article-title":"PID: the Pathway Interaction Database","volume":"37","author":"Schaefer","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database (Oxford)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinf"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbx085","article-title":"The BioCyc collection of microbial genomes and metabolic pathways","volume":"20","author":"Karp","year":"2019","journal-title":"Brief Bioinform"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1164","article-title":"The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway\/genome databases","volume":"44","author":"Caspi","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1101\/gr.772403","article-title":"PANTHER: a library of protein families and subfamilies indexed by function","volume":"13","author":"Thomas","year":"2003","journal-title":"Genome Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl229","article-title":"Applications for protein sequence-function evolution data: mRNA\/protein expression analysis and coding SNP scoring tools","volume":"34","author":"Thomas","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0273","article-title":"TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer","volume":"75","author":"Li","year":"2015","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1186\/s12885-018-4757-z","article-title":"Association of tamoxifen resistance and lipid reprogramming in breast cancer","volume":"18","author":"Hultsch","year":"2018","journal-title":"BMC Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/ijms18122543","article-title":"Protein Kinase Targets in Breast Cancer","volume":"18","author":"Garcia-Aranda","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1186\/bcr1536","article-title":"p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer","volume":"8","author":"Yamashita","year":"2006","journal-title":"Breast Cancer Res BCR"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1404","article-title":"Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study","volume":"106","author":"Puszkiel","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional Classification and Experimental Dissection of Long Noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12885-018-4155-6","article-title":"Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8","volume":"18","author":"Sootichote","year":"2018","journal-title":"BMC Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.510","article-title":"Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22","volume":"30","author":"Patel","year":"2011","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S188836","article-title":"miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1","volume":"11","author":"Wu","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B40","article-title":"Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast","volume":"7","author":"Zhao","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.03.019","article-title":"FoxD3 deficiency promotes breast cancer progression by induction of epithelial-mesenchymal transition","volume":"446","author":"Chu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.08.050","article-title":"Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity","volume":"12","author":"Simoes","year":"2015","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/emmm.201303411","article-title":"Sox2 promotes tamoxifen resistance in breast cancer cells","volume":"6","author":"Piva","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2018.1499131","article-title":"Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment","volume":"23","author":"Kim","year":"2018","journal-title":"Biomarkers"},{"key":"B45","first-page":"53","article-title":"LATS2 is a modulator of estrogen receptor alpha","volume":"33","author":"Lit","year":"2013","journal-title":"Anticancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2546","article-title":"Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer","volume":"13","author":"Cohen","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0285","article-title":"Estrogen receptor alpha regulates the expression of syndecan-1 in human breast carcinoma cells","volume":"26","author":"Fleurot","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.11.099","article-title":"miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1","volume":"469","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0035","article-title":"Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity","volume":"10","author":"deGraffenried","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e2454","DOI":"10.1038\/cddis.2016.361","article-title":"Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression","volume":"7","author":"Zhu","year":"2016","journal-title":"Cell Death Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/1471-2407-12-458","article-title":"Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan","volume":"12","author":"Hiscox","year":"2012","journal-title":"BMC Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13882","article-title":"STAT1 facilitates oestrogen receptor alpha transcription and stimulates breast cancer cell proliferation","volume":"22","author":"Hou","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1905973116","article-title":"The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells","volume":"116","author":"Yin","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10442","article-title":"Self-renewal of CD133(hi) cells by IL6\/Notch3 signalling regulates endocrine resistance in metastatic breast cancer","volume":"7","author":"Sansone","year":"2016","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"ra121","DOI":"10.1126\/scisignal.aaa1877","article-title":"Systematic identification of signaling pathways with potential to confer anticancer drug resistance","volume":"7","author":"Martz","year":"2014","journal-title":"Sci Signal"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.18","article-title":"Suppression of cell growth and invasion by miR-205 in breast cancer","volume":"19","author":"Wu","year":"2009","journal-title":"Cell Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1823","DOI":"10.1038\/cddis.2015.192","article-title":"miR-205-5p-mediated downregulation of ErbB\/HER receptors in breast cancer stem cells results in targeted therapy resistance","volume":"6","author":"De Cola","year":"2015","journal-title":"Cell Death Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41419-018-0854-9","article-title":"MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells","volume":"9","author":"De Cola","year":"2018","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.600487\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T20:02:42Z","timestamp":1606248162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.600487\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":59,"alternative-id":["10.3389\/fonc.2020.600487"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.600487","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"article-number":"600487"}}